English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The influence of cross-linking upon the kinetics of fibrinolysis has been studied in an in vitro system by monitoring the release of radioactive label, peptide materials, fragment X and D-dimer. Cross-linked (XL) and non-cross-linked (NXL) fibrin clots were prepared by clotting citrated plasma containing 125-I labelled fibrinogen with human thrombin, in the presence respectively of 40 mM Ca C12 or 2 mM EDTA, and incubating for 2 hours at 37°C. After washing, clots were placed in buffer containing human plasminogen (glu- or lys-) in concentrations ranging from 0 to 10 caseinolytic units per ml. Clots were transferred after 30 minutes to a solution of streptokinase (1000 units per ml) and the supernatants subsampled serially for 3 hours. NXL fibrin lysed progressively and sometimes completely. Maximal lysis rates were achieved with intermediate concentrations of plasminogen. XL fibrin lysed slowly and significant lysis was obtained only after exposure to the higher concentrations of lys-plasminogen. XL-fibrin lysed more readily after exposure to glu-plasminogen than to lys-plasminogen. Analysis of the chains in XL fibrin clots by SDS-polyacrylamide electrophoresis revealed the presence of a small residuum of NXL fibrin and incomplete cross-linkage of α chains. The NXL component lysed preferentially in streptokinase and the terminal clots contained only XL fibrin. Parallel effects may operate in vivo. The data support the contention that fibrinolytic mechanisms readily deal with NXL fibrin, and that only fibrin which has been XL occurs in thrombi and is of pathologic significance.

The Influence of Cross-Linking and Plasminogen on Kinetics of Fibrinolysis